Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;23(8):2004-2005.
doi: 10.1111/dom.14398. Epub 2021 Apr 23.

Parent and patient knowledge of nasal glucagon use and efficacy in a large cohort of Italian children and adolescents with type 1 diabetes

Ivana Rabbone  1 , Anna Missineo  1 , Sara Zanetta  1 , Giuseppina Salzano  2 , Riccardo Schiaffini  3 , Andrea E Scaramuzza  4 , Fortunato Lombardo  2
Affiliations
Comment

Parent and patient knowledge of nasal glucagon use and efficacy in a large cohort of Italian children and adolescents with type 1 diabetes

Ivana Rabbone et al. Diabetes Obes Metab. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Matsuhisa M, Takita Y, Nasu R, Nagai Y, Ohwaki K, Nagashima H. Nasal glucagon as a viable alternative for treating insulin-induced hypoglycaemia in Japanese patients with type 1 or type 2 diabetes: a phase 3 randomized crossover study. Diabetes Obes Metab. 2020;22:1167-1175.
    1. Thieu VT, Mitchell BD, Varnado OJ, Frier BM. Treatment and prevention of severe hypoglycaemia in people with diabetes: current and new formulations of glucagon. Diabetes Obes Metab. 2020;22:469-479.
    1. Suico JG, Hövelmann U, Zhang S, et al. Glucagon administration by nasal and intramuscular routes in adults with type 1 diabetes during insulin-induced hypoglycaemia: a randomised, open-label, crossover study. Diabetes Ther. 2020;11:1591-1603.
    1. Cherubini V, Rabbone I, Lombardo F, Mossetto G, Orsini Federici M, Nicolucci A. Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes in the real-life post-diabetes control and complications trial setting: a systematic review. Pediatr Diabetes. 2019;20(6):678-692.
    1. Yanai O, Phillip M, Harman I, Elitzur-Leiberman E, Pilpel D. IDDM patients' opinions on the use of glucagon emergency kit in severe episodes of hypoglycaemia. Pract Diabetes Int. 1997;14:40-42.

LinkOut - more resources